Innovative Pharmaceutical Biotech Financial Overview
Innovative Pharmaceutical Biotech's market cap is currently HK$212.14M. The company's EPS TTM is HK$-0.06; its P/E ratio is 14.92; Innovative Pharmaceutical Biotech is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
